| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2016PLoSO..1167374K |
| P356 | DOI | 10.1371/JOURNAL.PONE.0167374 |
| P932 | PMC publication ID | 5130269 |
| P698 | PubMed publication ID | 27902773 |
| P50 | author | Yae Kanai | Q91845764 |
| Hitoshi Nakagama | Q114872804 | ||
| Masako Ochiai | Q114873140 | ||
| Koji Okamoto | Q114873465 | ||
| Takahiro Yasui | Q40212291 | ||
| P2093 | author name string | Hiromi Sakamoto | |
| Teruhiko Yoshida | |||
| Masaru Katoh | |||
| Sumiko Ohnami | |||
| Keiichi Tozawa | |||
| Kenjiro Kohri | |||
| Noriyasu Kawai | |||
| Tadao Kakizoe | |||
| Katsuhiro Fukuta | |||
| Kazuhiro Kanemoto | |||
| P2860 | cites work | Analysis of heritability and shared heritability based on genome-wide association studies for thirteen cancer types | Q24170413 |
| A genetic polymorphism in coumarin 7-hydroxylation: sequence of the human CYP2A genes and identification of variant CYP2A6 alleles | Q24672583 | ||
| Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland | Q28140600 | ||
| Array-based comparative genomic hybridization for genome-wide screening of DNA copy number in bladder tumors. | Q46213171 | ||
| Mechanisms of chemopreventive effects of 8-methoxypsoralen against 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced mouse lung adenomas | Q46548981 | ||
| Association of NAT2, GSTM1, GSTT1, CYP2A6, and CYP2A13 gene polymorphisms with susceptibility and clinicopathologic characteristics of bladder cancer in Central China. | Q51756416 | ||
| A major role for CYP2A6 in nicotine C-oxidation by human liver microsomes. | Q52275435 | ||
| Synergistic cytotoxicity and apoptosis by Apo-2 ligand and adriamycin against bladder cancer cells. | Q54077975 | ||
| EAU guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2013 guidelines. | Q54391399 | ||
| Induction of urinary bladder tumors in ACI-N rats by butyl(3-carboxypropyl)nitrosoamine, a major urinary metabolite of butyl-(4-hydroxybutyl)nitrosoamine | Q69400553 | ||
| Induction of urinary bladder tumors by intravesicular instillation of butyl(4-hydroxybutyl)nitrosoamine and its principal urinary metabolite, butyl(3-carboxypropyl)nitrosoamine in rats | Q69758643 | ||
| Role of human cytochrome P4502A6 in C-oxidation of nicotine | Q71820851 | ||
| Genetic risk and carcinogen exposure: a common inherited defect of the carcinogen-metabolism gene glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder cancer | Q72804213 | ||
| CYP2A6 overexpression in human lung cancers correlates with a high malignant status | Q80429696 | ||
| Overexpression of CYP2A6 in human colorectal tumors | Q80759779 | ||
| Proteogenomic characterization of human colon and rectal cancer | Q28244320 | ||
| Comprehensive molecular characterization of urothelial bladder carcinoma | Q28306864 | ||
| Network of WNT and other regulatory signaling cascades in pluripotent stem cells and cancer stem cells | Q28609117 | ||
| Genome-wide association study identifies multiple loci associated with bladder cancer risk | Q28659283 | ||
| A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci | Q28943367 | ||
| Risk prediction scores for recurrence and progression of non-muscle invasive bladder cancer: an international validation in primary tumours. | Q33721258 | ||
| The impact of characteristics of cigarette smoking on urinary tract cancer risk: a meta-analysis of epidemiologic studies | Q33912702 | ||
| A sequence variant at 4p16.3 confers susceptibility to urinary bladder cancer | Q34071175 | ||
| Integrated genomic and gene expression profiling identifies two major genomic circuits in urothelial carcinoma | Q34299788 | ||
| Bladder cancer stage and outcome by array-based comparative genomic hybridization | Q34456640 | ||
| Copy number alterations in urothelial carcinomas: their clinicopathological significance and correlation with DNA methylation alterations | Q34734078 | ||
| Multistep carcinogenesis: a 1992 perspective | Q35425075 | ||
| Occupational risk factors for male bladder cancer: results from a population based case cohort study in the Netherlands. | Q35494568 | ||
| A strategy for investigating the CYP superfamily using targeted antibodies is a paradigm for functional genomic studies. | Q35587720 | ||
| Characterization of Dysplastic Aberrant Crypt Foci in the Rat Colon Induced by 2-Amino-1-Methyl-6-Phenylimidazo[4,5-b]Pyridine | Q35792168 | ||
| Cytochrome P450 gene polymorphism and cancer | Q35793926 | ||
| Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer | Q35855955 | ||
| Sequence variant on 8q24 confers susceptibility to urinary bladder cancer | Q35964294 | ||
| Molecular subtypes of bladder cancer: Jekyll and Hyde or chalk and cheese? | Q36341182 | ||
| Induction of minisatellite mutation in NIH 3T3 cells by treatment with the tumor promoter okadaic acid | Q36596063 | ||
| Genetic alterations in bladder cancer and their clinical applications in molecular tumor staging | Q36675078 | ||
| Genome-wide association study identified SNP on 15q24 associated with bladder cancer risk in Japanese population | Q36807462 | ||
| Bladder cancer epidemiology and genetic susceptibility | Q36878096 | ||
| Prevalence and co-occurrence of actionable genomic alterations in high-grade bladder cancer | Q37122307 | ||
| EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013. | Q38119345 | ||
| Lung tumorigenesis promoted by anti-apoptotic effects of cotinine, a nicotine metabolite through activation of PI3K/Akt pathway | Q39333131 | ||
| Downregulation of Ral GTPase-activating protein promotes tumor invasion and metastasis of bladder cancer | Q39373562 | ||
| Secreted CXCL1 is a potential mediator and marker of the tumor invasion of bladder cancer. | Q39986341 | ||
| Metabolic Fate ofN-n-Butyl-N-(4-hydroxybutyl)-nitrosamine and its Analogues: Selective Induction of Urinary Bladder Tumours in the Rat | Q40061902 | ||
| Sensitizing effect of galectin-7 in urothelial cancer to cisplatin through the accumulation of intracellular reactive oxygen species | Q40174189 | ||
| Bladder cancer outcome and subtype classification by gene expression | Q40414408 | ||
| Global gene expression analysis of rat colon cancers induced by a food-borne carcinogen, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine | Q40570898 | ||
| Synergistic cytotoxicity and apoptosis of JTE-522, a selective cyclooxygenase-2 inhibitor, and 5-fluorouracil against bladder cancer | Q40688646 | ||
| Genetic variation of CYP2A6, smoking, and risk of cancer. | Q44222316 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | bladder cancer | Q504775 |
| overexpression | Q61643320 | ||
| P304 | page(s) | e0167374 | |
| P577 | publication date | 2016-11-30 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Genomic Landscape of Experimental Bladder Cancer in Rodents and Its Application to Human Bladder Cancer: Gene Amplification and Potential Overexpression of Cyp2a5/CYP2A6 Are Associated with the Invasive Phenotype | |
| P478 | volume | 11 |
| Q41339763 | Insights from animal models of bladder cancer: recent advances, challenges, and opportunities |
| Q55503851 | Lumbrokinase/paclitaxel nanoparticle complex: potential therapeutic applications in bladder cancer. |
| Q100559757 | Pan-cancer driver copy number alterations identified by joint expression/CNA data analysis |
Search more.